PM2.5 activates IL-17 signaling pathway in human nasal mucosa-derived fibroblasts

Ying Zhu,Shiyao Zhang,Yuelong Gu,Xiwen Sun,Chunyu Luo,Jiayao Zhou,Zhipeng Li,Hai Lin,Weitian Zhang
DOI: https://doi.org/10.1016/j.intimp.2024.111484
IF: 5.714
2024-02-01
International Immunopharmacology
Abstract:Fine particulate matter (PM<sub>2.5</sub>) represents a prevalent environmental pollutant in the atmosphere, capable of exerting deleterious effects on human health. Numerous studies have indicated a correlation between PM<sub>2.5</sub> exposure and the development of chronic upper airway inflammatory diseases. The objective of this study was to investigate the impact of PM<sub>2.5</sub> on the transcriptome of fibroblasts derived from nasal mucosa. Initially, nasal mucosa-derived fibroblasts were isolated, cultured, and subsequently stimulated with PM<sub>2.5</sub> (100 μg/mL) or an equivalent volume of normal culture medium for a duration of 24 h. Following this, total RNA from these cells was extracted, purified, and subjected to sequencing using next-generation RNA sequencing technology. Differentially expressed genes (DEGs) were then identified and utilized for functional enrichment analysis. A protein-protein interaction (PPI) network of DEGs was constructed, and validation of key genes and proteins was carried out using quantitative real-time PCR and ELISA methods. Results revealed 426 DEGs, comprising 276 up-regulated genes and 150 down-regulated genes in nasal mucosa-derived fibroblasts treated with PM<sub>2.5</sub> compared to control cells. Functional enrichment analysis indicated that DEGs were predominantly associated with inflammation-related pathways, including the IL-17 signaling pathway. In alignment with this, PPI analysis highlighted that hub genes were primarily involved in the regulation of the IL-17 signaling pathway. Subsequent validation through quantitative real-time PCR and ELISA confirmed significant alterations in the relative expressions of IL-17 signaling pathway-related genes and concentrations of IL-17 signaling pathway related proteins in nasal mucosa-derived fibroblasts treated with PM<sub>2.5</sub> compared to control cells. In conclusion, PM<sub>2.5</sub> intervention substantially altered the transcriptome of nasal mucosa-derived fibroblasts. Furthermore, PM<sub>2.5</sub> has the potential to exacerbate the inflammatory responses of these fibroblasts by modulating the expression of key genes in the IL-17 signaling pathway.
pharmacology & pharmacy,immunology
What problem does this paper attempt to address?